0.6589
price up icon1.34%   +0.0087
 
loading

Evogene Ltd Aktie (EVGN) Neueste Nachrichten

StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - Defense World

pulisher
Defense World

Evogene (EVGN) Scheduled to Post Earnings on Thursday - Defense World

pulisher
Defense World

Evogene (NASDAQ:EVGN) Research Coverage Started at StockNews.com - Defense World

pulisher
Defense World

Evogene Schedules First Quarter 2024 Financial Results Release - BioSpace

pulisher
BioSpace

Evogene (NASDAQ:EVGN) Receives New Coverage from Analysts at StockNews.com - Defense World

pulisher
Defense World

Evogene Ltd. Announces Upcoming Annual Meeting - TipRanks.com - TipRanks

pulisher
TipRanks

Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting - PR Newswire

pulisher
PR Newswire

Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting - PR Newswire

pulisher
PR Newswire

Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein ... - PR Newswire

pulisher
PR Newswire

Evogene Ltd. Announces $7.3 Million Share Sale Plan - TipRanks.com - TipRanks

pulisher
TipRanks

Evogene Ltd. Announces $7.3 Million Share Sale Plan - TipRanks.com - TipRanks

pulisher
TipRanks

Evogene Ltd. Faces Nasdaq Compliance Challenge - TipRanks.com - TipRanks

pulisher
TipRanks

Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and ... - Krishak Jagat English

pulisher
Krishak Jagat English

Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and ... - PR Newswire

pulisher
PR Newswire

Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture ... - PR Newswire

pulisher
PR Newswire

Casterra and Evogene advance biobased castor seed production through strategic diversification - World Bio Market Insights

pulisher
World Bio Market Insights

Evogene Ltd. (NASDAQ:EVGN) Q4 2023 Earnings Call Transcript - Yahoo Finance

pulisher
Yahoo Finance

Evogene (EVGN) Reports Q4 Loss, Misses Revenue Estimates

pulisher
Zacks Investment Research

Evogene: Q4 Earnings Snapshot - Quartz

pulisher
Quartz

AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides - PR Newswire

pulisher
PR Newswire

Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite ... - PR Newswire

pulisher
PR Newswire

Israeli ag biological company partners with Corteva to license its products - The Packer

pulisher
The Packer

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates

pulisher
Zacks Investment Research

Corteva, Lavie Bio Finalize $5 Million Deal for Exclusive AI-Aided Development of Biofungicide - Agribusiness Global

pulisher
Agribusiness Global

Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement ... - PR Newswire

pulisher
PR Newswire

Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates

pulisher
Zacks Investment Research

Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024 - PR Newswire

pulisher
PR Newswire

Syngenta Crop Protection and Lavie Bio Forge Collaboration to Develop Biological Insecticidal Solutions - SynBioBeta

pulisher
SynBioBeta

AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control ... - PR Newswire

pulisher
PR Newswire

Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide - PR Newswire

pulisher
PR Newswire

Verb Biotics partners with Evogene to accelerate next-gen precision probiotics - NutraIngredients-usa.com

pulisher
NutraIngredients-usa.com

AI for Gut Health: Evogene and Verb Biotics Partner to Advance Probiotic Innovation - - HIT Consultant

pulisher
HIT Consultant

Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation - PR Newswire

pulisher
PR Newswire

Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit - PR Newswire

pulisher
PR Newswire

Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug - PR Newswire

pulisher
PR Newswire

Here's Why Evogene (EVGN) is a Great Momentum Stock to Buy

pulisher
Zacks Investment Research

Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024 - PR Newswire

pulisher
PR Newswire

Is Compugen (CGEN) Outperforming Other Medical Stocks This Year?

pulisher
Zacks Investment Research

Lavie Bio Forms Distribution Agreement with WinField United Canada for Its Bio-Inoculant Seed Treatment Yalos - Agribusiness Global

pulisher
Agribusiness Global

Bears are Losing Control Over Evogene (EVGN), Here's Why It's a 'Buy' Now

pulisher
Zacks Investment Research

Lavie Bio Expands Bio-Inoculant Product for Spring Wheat to Durum and Barley - CropLife

pulisher
CropLife

Evogene Reports Third Quarter 2023 Financial Results - PR Newswire

pulisher
PR Newswire

Lavie Bio Advances Biofungicide Toward Commercialization in U.S., Europe Trials - Agribusiness Global

pulisher
Agribusiness Global

New collaboration shows war-hit biotech company is moving on - ISRAEL21c

pulisher
ISRAEL21c

Evogene Provides Operational Update Amidst Current Security Situation in Israel - PR Newswire

pulisher
PR Newswire

Casterra delivers first shipment of castor seeds to Africa - World Bio Market Insights

pulisher
World Bio Market Insights

Casterra Delivers First Shipment of Castor Seeds to Africa - PR Newswire

pulisher
PR Newswire

Corteva Exclusively Licenses Lavie Bio Biofungicide Lineup - Agweb Powered by Farm Journal

pulisher
Agweb Powered by Farm Journal

Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center - PR Newswire

pulisher
PR Newswire

Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target ... - PR Newswire

pulisher
PR Newswire
$77.56
price up icon 0.77%
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
Kapitalisierung:     |  Volumen (24h):